1
|
Tuca AC, Bernardelli de Mattos I, Funk M, Markovic D, Winter R, Lemarchand T, Kniepeiss D, Spendel S, Hartmann B, Ottoman C, Kamolz LP. A Standardized Porcine Model for Partial-Thickness Wound Healing Studies: Design, Characterization, Model Validation, and Histological Insights. Int J Mol Sci 2024; 25:7658. [PMID: 39062901 PMCID: PMC11276889 DOI: 10.3390/ijms25147658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Revised: 07/02/2024] [Accepted: 07/10/2024] [Indexed: 07/28/2024] Open
Abstract
Wound healing is a complex process that is still not fully understood despite extensive research. To address this, we aimed to design and characterize a standardized porcine model for the evaluation of wound healing, dressings, cell therapies, and pharmaceutical agents. Using a standardized approach, we examined the wound healing process in 1.2 mm-deep dermatome wounds at defined positions in 11 female pigs. Unlike previous studies that have only described/analyzed selected punch biopsies, we performed and described histological analyses along the complete wound length using quantitative morphometric methods. All animals remained fully healthy following surgery and showed no signs of infection. Our histopathological evaluation using a predetermined grading score and quantitative manual morphometry demonstrated the impact of different tissue sampling methods, sampling sites, and residual dermis thickness on wound healing. Our study presents a reproducible model for wound healing evaluation and demonstrates the usefulness of porcine models for assessing dermal and epidermal wound healing. The use of histological analyses over the complete wound length provides advantages over previous studies, leading to the possibility of a deeper understanding of the wound healing process. This model could potentially facilitate future research on novel wound dressings and local wound healing therapies.
Collapse
Affiliation(s)
- Alexandru-Cristian Tuca
- Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria; (A.-C.T.); (R.W.); (S.S.); (L.-P.K.)
| | - Ives Bernardelli de Mattos
- Department of Tissue Engineering & Regenerative Medicine (TERM), University Hospital Würzburg, 97070 Würzburg, Germany
- EVOMEDIS GmbH, 8036 Graz, Austria;
| | | | - Danijel Markovic
- Core Facility Experimental Biomodels, Medical University of Graz, 8010 Graz, Austria;
| | - Raimund Winter
- Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria; (A.-C.T.); (R.W.); (S.S.); (L.-P.K.)
| | | | - Daniela Kniepeiss
- Division of General, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, 8010 Graz, Austria;
| | - Stephan Spendel
- Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria; (A.-C.T.); (R.W.); (S.S.); (L.-P.K.)
| | - Bernd Hartmann
- BG Klinikum Unfallkrankenhaus Berlin, 12683 Berlin, Germany; (B.H.); (C.O.)
| | - Christian Ottoman
- BG Klinikum Unfallkrankenhaus Berlin, 12683 Berlin, Germany; (B.H.); (C.O.)
| | - Lars-Peter Kamolz
- Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria; (A.-C.T.); (R.W.); (S.S.); (L.-P.K.)
- Joanneum Research Forschungsgesellschaft mbH, COREMED, 8010 Graz, Austria
| |
Collapse
|
2
|
Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB. Spray Film-Forming systems as promising topical in situ Systems: A review. Saudi Pharm J 2023; 31:154-169. [PMID: 36685308 PMCID: PMC9845128 DOI: 10.1016/j.jsps.2022.11.014] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Accepted: 11/18/2022] [Indexed: 11/24/2022] Open
Abstract
Spray film-forming systems (SFFSs) provide great potential for the treatment of various types of wounds. Such systems afford to prolong the action of active substances, to prevent cross-contamination, and to ensure accelerated wound healing. Spray films are known since the mid-20th century, and nowadays they are widely used to treat minor skin injuries, but numerous clinical cases describe their successful use in the treatment of burns, wounds, bedsores, etc. The current level of polymer development and composite synthesis has greatly expanded the possibilities of creating compositions of spray film-forming systems. Scattered information and lack of standardization of such delivery systems creates difficulties for pharmaceutical development. This review highlights most of the existing requirements and suggestions from studies to standardize the characteristics of SFFSs and classify them based on scientific sources and regulatory documentation, as well as the position of such systems in the pharmaceutical market. The search and evaluation of known characterization methods and their modifications, as well as the approval of their list (separately for development and for standardization) can potentially increase the research interest in the problem of spray film-forming systems development and contribute to the registration of new drugs and medical devices in this promising dosage form, including with its own pharmacological effect.
Collapse
|
3
|
Altoé LS, Alves RS, Sarandy MM, Morais-Santos M, Novaes RD, Gonçalves RV. Does antibiotic use accelerate or retard cutaneous repair? A systematic review in animal models. PLoS One 2019; 14:e0223511. [PMID: 31600279 PMCID: PMC6786583 DOI: 10.1371/journal.pone.0223511] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Accepted: 09/22/2019] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The presence of infections is one of the main factors that leads to delays in healing or non-closure of cutaneous wounds. Although the goal of antibiotic use is to treat or prevent infection, there is currently no agreement on the effectiveness of these products. AIM The aim of this study was to evaluate the efficacy of antibiotic use during the healing process of skin wounds in animal models not intentionally infected, as well as to analyze the advances and limitations of the studies carried out in this field. MAIN METHODS This systematic review was performed according to the PRISMA guidelines, using a structured search on the MedLine (PubMed) and Scopus platforms to retrieve studies published until August 29, 2018, 13:35p.m. The studies included were limited to those that used excision or incision wound models and that were not intentionally infected. The data for the animal models, antibiotic used, and the main results of the studies were extracted, and compared where possible. Bias analysis and methodological quality assessments were examined through the SYRCLE's Risk of Bias tool. KEY FINDINGS Twenty-seven studies were selected. Overall, the effects of the antibiotic on the wound decreased inflammatory cell infiltration and promoted an increased number of fibroblasts, extracellular matrix constituents, re-epithelialization and tissue strength. A great deal of important information about the methodology was not presented, such as: the statistical analysis used, the animal model (sex and age), antibiotic dosage, blinding and randomization of the animals chosen. SIGNIFICANCE Based on the results found, we believe that antibiotic therapy can be considered a viable alternative for the treatment of cutaneous wounds. However, current evidence obtained from the methodological quality analysis points towards a high risk of bias. This is due to the incomplete characterization of the experimental design and treatment protocol, which compromises the reproducibility of the studies.
Collapse
Affiliation(s)
| | - Raul Santos Alves
- Departament of General Biology, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil
| | | | - Mônica Morais-Santos
- Departament of Animal Biology, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil
| | - Rômulo Dias Novaes
- Departament of Structural Biology, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil
| | | |
Collapse
|
4
|
Abstract
INTRODUCTION/BACKGROUND Xeroform® is a petrolatum-based fine mesh gauze containing 3% bismuth tribromophenate. Bismuth, similar to other metals, has antimicrobial properties. Xeroform® has been used for decades in burn and plastic surgery as a donor site dressing and as a covering for wounds or partial thickness burns. Despite this, the antimicrobial spectrum of Xeroform® remains largely unknown. We examined the in-vitro efficacy of Xeroform® against common burn pathogens using zone-of-inhibition methodology in a commercial research facility. METHODS/DESIGN Pure strains of 15 common burn pathogens including Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus (MSSA), Staphylococcus epidermidis, Pseudomonas aeruginosa, Enterobacter cloacae, Escherichia coli, Candida albicans, Vancomycin resistant Enterococcus, Acinetobacter baumennii, Klebsiella pneumonia, Extended spectrum beta-lactamase producing Klebsiella, Beta hemolytic Streptococcus pyogenes, Proteus mirabilis, Serratia marcescens, and Salmonella enterica ssp. Enterica were inoculated at a strength of 106-1010 CFU/ml onto appropriate agar plates. A sterile 1 in2 Xeroform® square was placed in the center of each plate, and the Zone of Inhibition (ZOI) was measured following 18-24h of incubation at 37°C. A second bismuth pharmaceutical (bismuth subsalicylate, Pepto-Bismol®) was then tested using the same methodology against the same strains of MRSA, MSSA, E. coli, K. pneumonia and S. marcescens. Finally, 3% w/v bismuth tribromophenate in glycerol suspension was tested against 13 burn pathogens for antimicrobial activity independent of the Xeroform® dressing by measure of Zone of Inhibition. RESULTS/FINDINGS For Xeroform®, none of the fifteen pathogens had a measurable zone of inhibition on any plate. Bismuth subsalicylate showed a zone of inhibition for MSSA in 3 plates (mean of 47.2mm), in one of three plates for MRSA (13.8mm), and in one of three plates for S. marcesens (89.6mm). There was no zone of inhibition seen for K. pneumonia or E. coli. Bismuth tribromophenate, when not bound to Xeroform® showed activity against 12 of 13 pathogens. CONCLUSIONS/IMPLICATIONS While bismuth subsalicylate, and bismuth tribromophenate unbound to Xeroform® demonstrate antimicrobial activity, it appears that Xeroform® dressings do not. The utility of Xeroform® in burn medicine may relate more to use as an impervious dressing than to antimicrobial effect. Donor sites are clean surgical wounds and clean partial thickness burns may have minimal colonization present. In such circumstances, an inactive and impervious dressing may be all that is necessary to promote wound healing.
Collapse
|
5
|
Abstract
Acute and chronic pain control is a significant clinical challenge that has been largely unmet. Local anesthetics are widely used for the control of post-operative pain and in the therapy of acute and chronic pain. While a variety of approaches are currently used to prolong the duration of action of local anesthetics, an optimal strategy to achieve neural blockage for several hours to days with minimal toxicity has yet to be identified. Several drug delivery systems such as liposomes, microparticles and nanoparticles have been investigated as local anesthetic delivery vehicles to achieve prolonged anesthesia. Recently, injectable responsive hydrogels raise significant interest for the localized delivery of anesthetic molecules. This paper discusses the potential of injectable hydrogels to prolong the action of local anesthetics.
Collapse
|
6
|
|
7
|
Hanson SE, Kleinbeck KR, Cantu D, Kim J, Bentz ML, Faucher LD, Kao WJ, Hematti P. Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med 2013; 10:E90-E100. [PMID: 23418160 DOI: 10.1002/term.1700] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2012] [Revised: 12/09/2012] [Accepted: 12/20/2012] [Indexed: 12/18/2022]
Abstract
Wound healing remains a major challenge in modern medicine. Bone marrow- (BM) and adipose tissue- (AT) derived mesenchymal stromal/stem cells (MSCs) are of great interest for tissue reconstruction due to their unique immunological properties and regenerative potential. The purpose of this study was to characterize BM and AT-MSCs and evaluate their effect when administered in a porcine wound model. MSCs were derived from male Göttingen Minipigs and characterized according to established criteria. Allogeneic BM- or AT-MSCs were administered intradermally (1 x 10(6) cells) into partial-thickness wounds created on female animals, and covered with Vaseline® gauze or fibrin in a randomized pattern. Animals were euthanized at 7, 10, 14 and 21 days. Tissues were analyzed visually for healing and by microscopic examination for epidermal development and remodelling. Polymerase chain reaction (PCR) was used to detect the presence of male DNA in the specimens. All wounds were healed by 14 days. MSC-injected wounds were associated with improved appearance and faster re-epithelialization compared to saline controls. Evaluation of rete ridge depth and architecture showed that MSC treatment promoted a faster rate of epidermal maturation. Male DNA was detected in all samples at days 7 and 10, suggesting the presence of MSCs. We showed the safety, feasibility and potential efficacy of local injection of allogeneic BM- and AT-MSCs for treatment of wounds in a preclinical model. Our data in this large animal model support the potential use of BM- and AT-MSC for treatment of cutaneous wounds through modulation of healing and epithelialization.
Collapse
Affiliation(s)
- Summer E Hanson
- Division of Plastic and Reconstructive Surgery, Department of Surgery, UW-Madison, School of Medicine and Public Health.,Department of Surgery, UW-Madison, School of Medicine and Public Health.,Department of Biomedical Engineering, UW-Madison, College of Engineering
| | | | - David Cantu
- Division of Pharmaceutical Sciences, UW-Madison
| | - Jaeyhup Kim
- Department of Medicine, UW-Madison, School of Medicine and Public Health
| | - Michael L Bentz
- Division of Plastic and Reconstructive Surgery, Department of Surgery, UW-Madison, School of Medicine and Public Health.,Department of Surgery, UW-Madison, School of Medicine and Public Health
| | - Lee D Faucher
- Department of Surgery, UW-Madison, School of Medicine and Public Health
| | - W John Kao
- Division of Pharmaceutical Sciences, UW-Madison.,Department of Surgery, UW-Madison, School of Medicine and Public Health.,Department of Biomedical Engineering, UW-Madison, College of Engineering
| | - Peiman Hematti
- Department of Medicine, UW-Madison, School of Medicine and Public Health.,University of Wisconsin Carbone Cancer Center, UW-Madison, School of Medicine and Public Health, Madison, WI 53705, USA
| |
Collapse
|
8
|
Waldeck H, Kao WJ. Effect of the addition of a labile gelatin component on the degradation and solute release kinetics of a stable PEG hydrogel. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION 2012; 23:1595-611. [PMID: 21801489 DOI: 10.1163/092050611x587547] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Characterization of the degradation mechanisms and resulting products of biodegradable materials is critical in understanding the behavior of the material including solute transport and biological response. Previous mathematical analyses of a semi-interpenetrating network (sIPN) containing both labile gelatin and a stable cross-linked poly(ethylene glycol) (PEG) network found that diffusion-based models alone were unable to explain the release kinetics of solutes from the system. In this study, degradation of the sIPN and its effect on solute release and swelling kinetics were investigated. The kinetics of the primary mode of degradation, gelatin dissolution, was dependent on temperature, preparation methods, PEGdA and gelatin concentration, and the weight ratio between the gelatin and PEG. The gelatin dissolution rate positively correlated with both matrix swelling and the release kinetics of high-molecular-weight model compound, FITC-dextran. Coupled with previous in vitro studies, the kinetics of sIPN degradation provided insights into the time-dependent changes in cellular response including adhesion and protein expression. These results provide a facile guide in material formulation to control the delivery of high-molecular-weight compounds with concomitant modulation of cellular behavior.
Collapse
Affiliation(s)
- H Waldeck
- a Department of Biomedical Engineering , College of Engineering, University of Wisconsin-Madison , 777 Highland Avenue , Madison , WI , 53705 , USA
| | | |
Collapse
|
9
|
Xu K, Kleinbeck KR, Kao WJ. Multifunctional Biomaterial Matrix for Advanced Wound Healing. Adv Wound Care (New Rochelle) 2012; 1:75-80. [PMID: 24527284 DOI: 10.1089/wound.2011.0349] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2011] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Modern wound dressings provide a moist healing environment and facilitate faster and higher quality of healing. A new semi-interpenetrating network (sIPN) biomaterial platform based on poly(ethylene glycol) (PEG) and gelatin was developed as a multi-functional matrix for wound care. THE PROBLEM Besides providing a moist environment and facilitating the healing process, advanced wound dressings may be designed to serve as delivery matrices for drugs and therapeutic cells. New and effective treatments should also comply with clinical settings and be easy to use. No single treatment exists today that can fulfill all these requirements; however, advancement in multifunctional biomaterial design and development holds promise to fill this technology gap. BASIC/CLINICAL SCIENCE ADVANCES PEG + gelatin sIPN provides an ideal platform for fundamental research in cell-cell and cell-biomaterial interaction that is important in wound healing. The in situ forming ability of sIPN facilitates its use in large and irregular wounds with complex contours and crevices. CLINICAL CARE RELEVANCE Although various commercially available wound dressings have been produced, a low-cost, easy-to-use, and biofunctionalizable biomaterial that provides a moist environment and facilitates healing is still a target of active tissue regeneration research. CONCLUSION Extensive preclinical data support the use of in situ polymerized sIPN in advanced wound care.
Collapse
Affiliation(s)
- Kedi Xu
- Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin—Madison, Madison, Wisconsin
- Department of Biomedical Engineering, College of Biomedical Engineering and Instrumental Science, Zhejiang University, People's Republic of China
| | - Kyle R. Kleinbeck
- Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin—Madison, Madison, Wisconsin
| | - Weiyuan John Kao
- Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin—Madison, Madison, Wisconsin
- Department of Biomedical Engineering, College of Engineering, University of Wisconsin—Madison, Madison, Wisconsin
- Department of Surgery, School of Medicine and Public Health, University of Wisconsin—Madison, Madison, Wisconsin
| |
Collapse
|